The Smoking Cessation Pill, varenicline, has emerged as a groundbreaking solution for those aiming to quit vaping, especially among teens and young adults.Recent research from Harvard-affiliated Mass General Brigham highlights that participants aged 16 to 25 who took this FDA-approved pill experienced over three times the success rate in quitting compared to those receiving only behavioral counseling.